Employing the pharmacological inhibitor MDL72527 and the EAE model of MS, the present study investigates the impact of SMOX inhibition on optic nerve myelination, axonal integrity, and changes in retinal function. This evidence concerns the gene SMOX and myeloid sarcoma.